Andrew T. Chan, MD, MPH is a gastroenterologist, the Daniel K. Podolsky Professor of Medicine at Harvard Medical School, Professor of Immunology and Infectious Diseases at Harvard T. H. Chan School of Public Health, Chief of the Clinical and Translational Epidemiology Unit at Massachusetts General Hospital, and Director of Epidemiology at the MGH Cancer Center. Dr. Chan’s research focuses on prevention and treatment of gastrointestinal cancers. He is the Team Lead for the Stand Up to Cancer Gastric Cancer Interception Team, co-Team Lead for the Cancer Grand Challenges Early-Onset Cancer Team (PROSPECT).
In his lecture this year at EHTG, Prof. Chan will talk about hereditary colorectal cancer prevention by aspirin and discuss risks and benefits of this preventive approach.

Sir Harpal Kumar

GRAIL Europe

Prof. Phil Quirke

University of Leeds, UK

Prof. Sir John Burn

Newcastle University, UK

Dr. Mev Dominguez-Valentin

Oslo University Hospital, Norway

Prof. Dr. Silvia Stacchiotti

Fondazione IRCCS INT, Italy

Prof. Yann Parc

Saint-Antoine Hospital, France

Dr. Neil Ryan

Edinburgh University, UK

Caroline Kahn

Copenhagen University Hospital, Denmark

Prof. Andrew T. Chan

Harvard Medical School, USA

Prof. Ann-Sofie Backman

Karolinska Institute, Sweden

Prof. Matthias Kloor

Heidelberg University Hospital, Germany

Prof. Richard Anderson

University of Edinburgh, UK

Programme

All About the 8th Annual EHTG Meeting

We are delighted to invite you to the 8th annual EHTG meeting which will take place on the 27th and 28th of September 2024 – online!

The time scheduled in the programme is referring to CET (Central European Time).

This template is made with by Colorlib
+